Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- ACOG practice bulletin No. 121: long-acting reversible contraception: implants and intrauterine devices.Obstet Gynecol. 2011; 118: 184-196
- Contraceptive discontinuation attributed to method dissatisfaction in the United States.Contraception. 2007; 76: 267-272
Bayer Healthcare Pharmaceuticals Inc. Skyla prescribing information. 2013. Available at: http://labeling.bayerhealthcare.com/html/products/pi/Skyla_PI.pdf. Accessed August 17, 2015.
- Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).Fertil Steril. 1994; 61: 70-77
- Bleeding related to etonogestrel subdermal implant in a US population.Contraception. 2011; 83: 426-430
- The effects of Implanon on menstrual bleeding patterns.Eur J Contracept Reprod Health Care. 2008; 13: 13-28
- Ibuprofen prevents IUCD-induced increases in menstrual blood loss.Br J Obstet Gynaecol. 1986; 93: 285-288
- Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.Contraception. 1996; 54: 201-208
- A three-year evaluation of TCu 380 Ag and multiload Cu 375 intrauterine devices.Contraception. 1988; 38: 631-639
- Role of prostaglandins in IUD-associated uterine bleeding–effect of a prostaglandin synthetase inhibitor (ibuprofen).Obstet Gynecol. 1981; 58: 101-106
- Treatment of increased menstrual blood loss in IUD users.Contraception. 1987; 36: 145-157
- Randomized multi-center study of baofuxin for treatment of bleeding side-effect induced by IUD.Reprod Contracept. 2000; 11: 152-157
- Effect of meclofenamic acid on menstruation in hypermenorrheic women using intrauterine devices.Rev Chil Obstet Ginecol. 1988; 53 ([in Spanish]): 43-56
- Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study.Hum Reprod. 2003; 18: 2319-2322
- Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.Br J Obstet Gynaecol. 1983; 90: 78-83
- The effect of acetylsalicylic acid on menstrual blood loss in women with IUDs.Contraception. 1987; 36: 295-303
- Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women.Acta Obstet Gynecol Scand. 2007; 86: 1126-1129
- Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years.Contraception. 2002; 65: 129-132
- Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial.Am J Obstet Gynecol. 2012; 206: e1-e8
- Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.Obstet Gynecol. 2013; 121: 934-941
- Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system.Int J Gynaecol Obstet. 2010; 109: 128-130
- Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding.Hum Reprod. 2010; 25: 345-353
- Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.Fertil Steril. 2009; 91: 1646-1653
- A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.Contraception. 1999; 60: 1-8
- U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.MMWR Recomm Rep. 2013; 62: 1-60
- The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.Contraception. 2011; 83: 202-210
- The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use.Contraception. 2006; 73: 253-256
- Management of etonogestrel subdermal implant-related bleeding.J Reprod Med. 2014; 59: 306-312
- The effect of mefenamic acid on controlling irregular uterine bleeding second to Implanon use.J Med Assoc Thai. 2004; 87: S64-S68
- A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.Hum Reprod. 2006; 21: 295-302
- A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.Hum Reprod. 2009; 24: 1852-1861
Article info
Publication history
Published online: September 15, 2015
Identification
Copyright
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
